News
In response to FDA safety review of mifepristone, 4 pro-abortion states hit back
Days after FDA Commissioner Marty Makary said that the agency planned to review the safety of abortion pill mifepristone, attorneys general from four pro-abortion states have fired back, filing (PDF) a petition asking the U.S. regulator to lift restrictions on the treatment.
Food and Drug Administration Commissioner Marty Makary committed to reviewing the abortion drug mifepristone in a letter sent to Senator Josh Hawley (R-Mo.). “As with all drugs, FDA continues to ...
Mo., had a heated exchange with a liberal law professor over the spike in nationwide injunctions against Trump's executive ...
Kate Shaw, Professor of Law University of Pennsylvania Carey Law School, testifies during a Senate Committee on the Judiciary ...
The Food and Drug Administration commissioner has committed to reviewing the abortion drug mifepristone after previously ...
Thanks to These Stellar Men and a Bogus Study, the FDA Will Needlessly Investigate the Abortion Pill
Dr. Marty Makary said Monday that the FDA will review the pill’s safety, after Sen. Josh Hawley amplified a bogus “study” on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback